公开(公告)号：EP1579001A2

公开(公告)日：2005-09-28

申请号：EP03722001.9

申请日：2003-04-30

申请人： UNIVERSITY OF SOUTH FLORIDA

发明人： MOHAPATRA, Shyam S. ,  BEHERA, Aruna K.

IPC分类号： C12Q1/68 ,  C12P19/34 ,  C12N15/68 ,  C07H21/02 ,  C07H21/04 ,  A01N43/04

CPC分类号： A61K38/45 ,  A61K38/217 ,  A61K38/51 ,  A61K48/00 ,  A61K48/005 ,  C12N9/1241 ,  C12N2710/10343 ,  C12N2799/022

摘要： The subject invention concerns a method of inhibiting an RNA virus infection within a patient by increasing the amount of 2-5 oligoadenylate (2-5 AS) activity within the patient. Preferably, the preventive and therapeutic methods of the present invention involve administering a nucleotide encoding 2-5 AS, or at least one catalytically active fragment thereof, such as the p40, p69, p100 subunits to a patient in need thereof. The present inventors have determined that overexpression of 2-5AS causes a reduction in epithelial cell damage, reduction in infiltration of mononuclear cells in the peribronchiolar and perivascular regions, and reduction in thickening of the septa in the lungs. Levels of chemokines, such as MIP1-α, are also reduced upon overexpression of 2-5AS. The subject invention also pertains to pharmaceutical compositions containing a nucleotide sequence encoding 2-5AS and pharmaceutically acceptable carrier, as well as vectors for delivery of the 2-5AS nucleotide sequence.

公开(公告)号：EP1579001B1

公开(公告)日：2013-02-13

申请号：EP03722001.9

申请日：2003-04-30

申请人： UNIVERSITY OF SOUTH FLORIDA

发明人： MOHAPATRA, Shyam S. ,  BEHERA, Aruna K.

IPC分类号： A61K38/51 ,  A61K38/21 ,  A61K48/00 ,  A61P31/14

CPC分类号： A61K38/45 ,  A61K38/217 ,  A61K38/51 ,  A61K48/00 ,  A61K48/005 ,  C12N9/1241 ,  C12N2710/10343 ,  C12N2799/022